IFN-ε Is Constitutively Expressed by Cells of the Reproductive Tract and Is Inefficiently Secreted by Fibroblasts and Cell Lines

Type-I interferons (IFNs) form a large family of cytokines that primarily act to control the early development of viral infections. Typical type-I IFN genes, such as those encoding IFN-α or IFN-β are upregulated by viral infection in many cell types. In contrast, the gene encoding IFN-ε was reported to be constitutively expressed by cells of the female reproductive tract and to contribute to the protection against vaginal infections with herpes simplex virus 2 and Chlamydia muridarum. Our data confirm the lack of induction of IFN-ε expression after viral infection and the constitutive expression of IFN-ε by cells of the female but also of the male reproductive organs. Interestingly, when expressed from transfected expression plasmids in 293T, HeLa or Neuro2A cells, the mouse and human IFN-ε precursors were inefficiently processed and secretion of IFN-ε was minimal. Analysis of chimeric constructs produced between IFN-ε and limitin (IFN-ζ) showed that both the signal peptide and the mature moiety of IFN-ε contribute to poor processing of the precursor. Immunofluorescent detection of FLAG-tagged IFN-ε in transfected cells suggested that IFN-ε and chimeric proteins were defective for progression through the secretory pathway. IFN-ε did not, however, act intracellularly and impart an antiviral state to producing cells. Given the constitutive expression of IFN-ε in specialized cells and the poor processing of IFN-ε precursor in fibroblasts and cell lines, we hypothesize that IFN-ε secretion may require a co-factor specifically expressed in cells of the reproductive organs, that might secure the system against aberrant release of this IFN.

[1]  Charles M. Rice,et al.  Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response , 2015, Nature.

[2]  J. Rossjohn,et al.  Interferon-ε Protects the Female Reproductive Tract from Viral and Bacterial Infection , 2013, Science.

[3]  P. Staeheli,et al.  Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. , 2012, Immunity.

[4]  J. Casanova,et al.  Evolutionary genetic dissection of human interferons , 2011, The Journal of experimental medicine.

[5]  S. Brunak,et al.  SignalP 4.0: discriminating signal peptides from transmembrane regions , 2011, Nature Methods.

[6]  G. Cheng,et al.  New developments in the induction and antiviral effectors of type I interferon. , 2011, Current opinion in immunology.

[7]  F. Blecha,et al.  Differential expression and activity of the porcine type I interferon family. , 2010, Physiological genomics.

[8]  S. Smirnov,et al.  Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus , 2007, Proceedings of the National Academy of Sciences.

[9]  Z. Duan,et al.  Purification of recombinant human interferon-ε and oligonucleotide microarray analysis of interferon-ε-regulated genes ☆ , 2007 .

[10]  T. Michiels,et al.  N-glycosylation of murine IFN-beta in a putative receptor-binding region. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[11]  F. Weber,et al.  Neurons produce type I interferon during viral encephalitis , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Michiels,et al.  Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness. , 2006, The Journal of general virology.

[13]  J. Renauld,et al.  Characterization of the Murine Alpha Interferon Gene Family , 2004, Journal of Virology.

[14]  L. Jermiin,et al.  Characterization of the type I interferon locus and identification of novel genes. , 2004, Genomics.

[15]  Y. Matsuzawa,et al.  Antiviral Activity of Limitin against Encephalomyocarditis Virus, Herpes Simplex Virus, and Mouse Hepatitis Virus: Diverse Requirements by Limitin and Alpha Interferon for Interferon Regulatory Factor 1 , 2003, Journal of Virology.

[16]  Y. Matsuzawa,et al.  Type I interferons and limitin: a comparison of structures, receptors, and functions. , 2001, Cytokine & growth factor reviews.

[17]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[18]  T. Michiels,et al.  Absence of Internal Ribosome Entry Site-Mediated Tissue Specificity in the Translation of a Bicistronic Transgene , 1999, Journal of Virology.

[19]  T. Michiels,et al.  Protein 2A is not required for Theiler's virus replication , 1997, Journal of virology.

[20]  A. Campbell,et al.  Nuclear localisation of calreticulin in vivo is enhanced by its interaction with glucocorticoid receptors , 1997, FEBS letters.

[21]  G. Duke,et al.  Attenuation of Mengo virus through genetic engineering of the 5′ noncoding poly(C) tract , 1990, Nature.

[22]  J. Miller,et al.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system , 1987, Molecular and cellular biology.

[23]  S. Aaronson,et al.  Development of 3T3‐like lines from Balb/c mouse embryo cultures: Transformation susceptibility to SV40 , 1968, Journal of cellular physiology.

[24]  J. Lindenmann,et al.  Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.

[25]  S. Goodbourn,et al.  Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. , 2008, The Journal of general virology.

[26]  Z. Duan,et al.  Purification of recombinant human interferon-epsilon and oligonucleotide microarray analysis of interferon-epsilon-regulated genes. , 2007, Protein expression and purification.

[27]  G. Schreiber,et al.  The receptor of the type I interferon family. , 2007, Current topics in microbiology and immunology.

[28]  T. Michiels,et al.  Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. , 2003 .